|
Volumn 81, Issue 2, 1992, Pages 170-177
|
A randomized study of intermediate versus conventional‐dose cytarabine as intensive induction for acute myelogenous leukaemia
a a a a a a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTARABINE;
DAUNORUBICIN;
ETOPOSIDE;
MITOXANTRONE;
ACUTE GRANULOCYTIC LEUKEMIA;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
FEMALE;
HUMAN;
HUMAN CELL;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MUCOSA INFLAMMATION;
NAUSEA;
NEUROTOXICITY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SKIN DISEASE;
VOMITING;
ADOLESCENT;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYTARABINE;
DAUNORUBICIN;
FEMALE;
HUMAN;
LEUKEMIA, MYELOCYTIC, ACUTE;
MALE;
MIDDLE AGE;
REMISSION INDUCTION;
|
EID: 0026623044
PISSN: 00071048
EISSN: 13652141
Source Type: Journal
DOI: 10.1111/j.1365-2141.1992.tb08203.x Document Type: Article |
Times cited : (35)
|
References (21)
|